Yoğun bakım trakeostomi deneyimlerimiz; 103 olgu Our tracheostomy experiences in intensive care; 103 cases Amaç: Bu çalışmada, yoğun bakım ünitemizde Griggs tekniği ile açılan perkütan trakeostomilerin işlemlerinin erken komplikasyonları sunmayı amaçladık. Gereç ve Yöntem: Çalışmamızda, 2010-2016 yılları arasında Griggs tekniği ile perkütan trakeostomi açılan, 37 erkek 66 kadın olgu incelendi. Boyun yapısı normal olan ve hemostatik bozukluğu olmayan hastalar çalışmaya dahil edildi. Bulgular: Hastaların hepsinde perkütan trakeostomi başarılı bir şekilde açıldı. Komplikasyon olarak 6 hastada minör kanama, 15 hastada hipotansiyon, 1 hastada yara yeri enfeksiyonu görüldü. Hastalarda pnömotoraks, ciddi hipoksi ve mortalite görülmedi. Sonuç: Griggs tekniği ile perkütan trakeostomi açılmasının yatak başında kısa sürede uygulanan, düşük komplikasyon oranına sahip bir yöntem olduğu kanaatine varıldı. Anahtar Sözcükler: Komplikasyon; perkütan trakeostomi; yoğun bakım. Introduction: In this study we aimed to present the early complications of the percutaneous tracheotomies with Griggs technique in our intensive care unit. Methods: In this study, we investigated 103 patients. Percutaneous tracheostomy with Griggs method were performed to all patients. This study performed between 2010-2016. 37 male, 66 female patients were investigated. Normal tracheal and neck structurel patients were selected for technique. There were also no hemostatic problem. Peroperative and postoperative complications were recorded. Results: Percutaneous tracheostomies were performed succesfully in all patients. Minör bleeding were seen on 6 patients, hypotension on 15 patients, wound infection on 1 patient. Pneumothorax, serious hypoxia and mortality were not seen during percutaneous tracheostomy. Discussion and Conclusion: We conclude that percutaneous tracheostomy with Griggs technique is performed in a short time at the bedside and has a low complication ratio.
Objective: Corrosive burns of the esophagus are some reports demonstrating that the stricture ratio exceeds 50% in the case of a severe burn. In this experimental animal study of rats, we aimed to investigate the effects of the anti-inflammatory agents in esophageal alkali burns. Methods: Twenty-eight Wistar albino rats, weighing from 220 to 250 gr, were used in the study. And following a starving period of 12 hours, we provided general anesthesia with intramuscular ketamin HCL (90 mg/kg) and xylazine (10mg/kg). A corrosive burn just like the corrosive esophagitis was done under general anesthesia. The rats were divided into four groups (7 rats for each). The intraluminal area of 1cm in the esophagus of the rats of the first group was washed using serum physiologic (1 ml). Group II received parenteral antibiotic treatment. Group III received antibiotic and dexamethasone regiment, while the Group IV received antibiotic and prednisolone. Each animal was sacrificed on the 21 st day, and their abdominal esophagus was resected for histopathological investigation. The submucosal increase in the collagen, damage to the muscularis mucosa and to the tunica muscularis were three parameters demonstrating the injury histopathologically. Results: There was no injury in the Group I. There was injury in each parameter in the Group II, III, and IV compared with Group I. In the comparison between Group II and III, there was less injury in the Group III. In comparison with Group II there was also significant injury in the muscularis mucosa and the tunica muscularis in the Group I (p<0.05). Conclusion: Prednisolone may decrease the new collagen synthesis that progresses up to muscularis mucosa, but the effect on the lowering the stricture formation is not better than dexamethasone.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.